Electra Therapeutics, Inc.'s next confirmed earnings release is scheduled for March 3, 2027.
| Earnings Date | 3/3/2027 |
As of June 30, 2026, Electra Therapeutics, Inc. has 62.77M shares outstanding.
| Shares Outstanding | 62.77M |
As of June 30, 2026, Electra Therapeutics, Inc. maintains a current ratio of 7.37, meaning it holds 7.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 7.37 |
| Quick Ratio | 7.19 |
| Debt / Equity | -7.41 |
As of June 30, 2026, Electra Therapeutics, Inc. holds 97.73M in cash and equivalents against 1.98M in total debt, resulting in a net debt position of -66.51M. Total book value stands at -219.45M, with working capital of 86.74M providing operational flexibility.
| Cash & Cash Equivalents | 97.73M |
| Total Debt | 1.98M |
| Net Debt | -66.51M |
| Equity (Book Value) | -219.45M |
| Book Value Per Share | -3.50 |
| Working Capital | 86.74M |